Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Olga Sribna

National Scientific Center, Ukraine

Title: Dynamics in cardiovascular diseases risk factors prevalence among females of working age, based on results of 35years monitoring

Biography

Biography: Olga Sribna

Abstract

Goal: The goal is to evaluate the long-term dynamics of the epidemiological conditions of CVD formation among females living in urban area.

Material and Methods: During 2015-20161018 men aged 18-64 years were examined. The findings were compared to the results of similar design studies, executed in 1980 (1148 people), 2000 (1025 persons), 2005 (967 persons) and 2010 (1076 persons).

Results: When persistent changes in such risk factors prevalence hypertension (27-31 %) and obesity (30-28 %) along with the decrease in encountering overweight(from 38 to 28 %, Ñ€<0,01)  are absent we register vivid and reliable increase in the number of individuals with hypodynamia (from 36 to 55 %, Ñ€<0,001) and hypercholesterolemia(from 39  to 61 %,Ñ€<0,01). From 1980 to 2000 we see 4 times increase in smoking frequency (from 5 to 20 %). The results of the further research show the lack of significant changes in this indicator. One of the important manifestations in risk profile deterioration is the increase of associativity inidentified risk agents: percent of the individuals with one risk factor decreased 2 times and the part of the females with the combination of 3 and more risk factors increased 4 times.

Conclusion: Negative risk profile dynamics among urban females testifies about the increase among the population as a whole of the cohort of individuals with high risl of CVD development and respectively speaks about the decrease in population health indicators.  It is necessary to develop and introduce active prophylaxis measures to improve epidemiological conditions for CVD formation among population.